demonstrated that in patients with metabolic syndrome, metabolic syndrome plus inflammation, and type 2 diabetes mellitus, plasma ANGPTL4 and TG levels were higher than the healthy controls while the HDL‐C levels were significantly lower.1 This evidence concerns the gene ANGPTL4 and type 2 diabetes mellitus.